Aixial Group

Aixial Group

Aixial Group is a leader in CRO services with expertise in oncology, cell & gene, and rare disease therapies that spans the entire development of pharmaceuticals, biologics, and devices. With more than 1,000 employees worldwide, Aixial provides expertise and a wide range of solutions, including full-service, FSP, and consulting.

Visit Website

Locations

  • APAC
  • Europe
  • North America
  • South America

Therapeutic Areas

  • Cardiovascular
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Immunology
  • Infectious Diseases
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Respiratory

Accreditations

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.